|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Effects of sparfloxa- cin, grepafloxacin, moxi-floxacin, and ciprofloxacin on cardiac action potential duration显示文摘 | Patmore L Fraser S Mair D | 2000 | Eur J Pharmacol2000，406，3： | 1 |
| 2 | Electrical properties of carbon nanotube based fibers and their future use in electrical wiring 显示文摘 | LEKAWA R A PATMORE J KURZEPA L | 2014 | Adv Funct Mater2014，24，24： | 1 |
| 3 | Can a genetic signature for metastatic head and neck squamous cell carcinoma be characterised by comparative genomic hybridisation显示文摘 | PATMORE H S ASHMAN J N CAWKWELL L | 2004 | Br J Cancer2004，90，10： | 1 |
| 4 | Effects of sparfloxacin,grepafloxacin,moxifloxacin,and ciprofloxacin on cardiac action potential duration显示文摘 | Patmore L Fraser S Mair D | 2000 | Eur J Pharmacol2000，406，3： | 1 |
| 5 | Effects of sparfloxacin,grepafloxacin,moxi-floxacin,and ciprofloxacin on cardiac action potential duration显示文摘 | Patmore L Fraser S Mair D | 2000 | Eur J Pharmacol2000，406，3： | 1 |
| 6 | Effects of the neuroprotective agent,KB- 2796,on the voltage- depe-ndent sodium current in mouse neuroblastoma,N1E- 115显示文摘 | Patmore L Sheridan RD | 1994 | Rd Proc Br Pharmacol Soc1994，1316，： | 1 |
| 7 | Effects of sparfloxacin, grepafloxacin, moxifloxacin, and ciprofloxaein on cardiac action potential duration显示文摘 | Patmore L Fraser S | 2000 | Euro J of Phar-macol2000，406，3： | 1 |
| 8 | Effects of sparfloxacin, grepafloxacin, moxifloxacin,andciprofloxacin on cardiac action potential duration显示文摘 | Patmore L Fraser S | 2000 | Euro J of Pharmacol2000，406，3： | 1 |
| 9 | 抗心绞痛药物丹参的主要成份丹参酮Ⅱ-A磺酸盐的钙内流阻滞作用显示文摘 | Patmore L 朱伯卿 | 1983 | 国外医学心血管疾病分册1983，，04： | 1 |
| 10 | Protective effects ofranolazine in guinea-pig hearts during low-flow isehaemia and their association with increases in active pyruvate debydrogenase显示文摘 | Clarke B Spedding M Patmore L | 1993 | Br J Pharmacol1993，109，3： | 1 |
| 11 | Bcl-2 expression predicts radiotherapy failure in laryngeal cancer 显示文摘 | Nix P Cawkwell L Patmore H | 2005 | Br J Cancer2005，92，12： | 1 |
| 12 | Calcium entry blocking properties of tanshinone ⅡA sulphonate,an active principal of the antianginal extract,Danshen显示文摘 | Patmore L Whiting RL | 1982 | Br J Pharmacol1982，，： | 1 |
| 13 | Calcium entry blocking properties of tanshinone ⅡA sulphonate,an active principal of the antianginal extract,Danshen显示文摘 | Patmore L Whiting R L | 1982 | Br J Pharmacol1982，，： | 1 |
| 14 | Calcium entry blocking properties of Sodium tanshinone ⅡA sulfonate sulphonate,an active principal of the antianginal extract,Danshen显示文摘 | Patmore L Whiting RL | 1982 | Br J Pharmacol1982，，： | 1 |
| 15 | Chinese medicine several common adversereactions 显示文摘 | Patmore L | 2007 | Anqing Medicine2007，，2： | 1 |
| 16 | Effects of the antiepileptic drugs lamotrigine, topiramate and gabapentin on hERG potassiumcurrents显示文摘 | Danielsson BR Landsdell K Patmore L | 2005 | Epilepsy Res2005，63，： | 1 |
| 17 | Effects of the neuroprotective agent,KB-2796,on t he voltage dependent sodium current in mouse neuroblastoma,N1E-115显示文摘 | Sheridan RD | 1994 | Proc Br Pharmacol Soc1994，148，： | 1 |
| 18 | Effects of sparfloxacin,grepafloxacin,moxifloxacin,and ciprofloxacin on cardiac action potential duration显示文摘 | Patmore L Fraser S Mair D | 2000 | Eur J Pharmacol2000，406，3： | 1 |
| 19 | Effects of sparfloxacin, grepafloxacin, moxifloxacin, and ciprofloxacin on cardiac action potential duration 显示文摘 | Patmore L Fraster S Mair D | 2000 | Eur J Pharmacol2000，406，： | 1 |
| 20 | Effects of sparfloxacin, grepatloxacin, moxifloxacin, andciprofloxacin on cardiac action potential duration显示文摘 | Patmore L Fraser S | 2000 | Euro J Pharmacol2000，406，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员